From: Validation of administrative health data for the pediatric population: a scoping review
Study characteristic ( N = 37) | n(%) |
---|---|
Year of publication | Â |
Prior to 2001 | 4 (10.8) |
2001-2005 | 10 (27.0) |
2006-2010 | 11 (29.7) |
2011-2012 | 12 (32.4) |
Country of origin | Â |
USA | 16 (43.2) |
Canada | 9 (24.3) |
Denmark | 3 (8.1) |
New Zealand | 3 (8.1) |
China | 2 (5.4) |
United Kingdom | 2 (5.4) |
Other | 2 (5.4) |
Age group ( years ) a | Â |
0 - 5 | 29 (78.3) |
6 - 10 | 21 (56.7) |
11 - 15 | 29 (54.0) |
16 - 20 | 17 (45.9) |
Condition validated | Â |
Diabetes | 4 (10.8) |
Inflammatory bowel disease | 2 (5.4) |
Asthma | 2 (5.4) |
Rotavirus infection | 2 (5.4) |
Tuberculosis | 2 (5.4) |
Other | 25 (67.6) |
Topic of validation | Â |
Diagnosis codes only | 14 (37.8) |
Case-finding algorithm | 21 (56.8) |
Both | 2 (5.4) |
Administrative data source | Â |
Inpatient | 25 (65.8) |
Outpatient | 9 (23.7) |
Emergency department | 2 (5.3) |
Pharmacy | 2 (5.3) |
Diagnosis coding system a | Â |
ICD-9 or ICD-9-CM | 28 (75.7) |
ICD-10 or ICD-10-CA | 8 (21.6) |
Other | 2 (5.4) |
Validation data source a | Â |
Medical chart | 23 (62.2) |
Disease registry | 6 (16.2) |
Clinical database | 4 (10.8) |
Laboratory data | 4 (10.8) |
Survey | 2 (5.4) |
Validation measure a | Â |
Sensitivity | 24 (64.8) |
Specificity | 20 (54.0) |
PPVb | 17 (45.9) |
NPVc | 8 (21.6) |
Otherd | 4 (10.8) |